HSCS

HeartSciences Inc.

2.90

Top Statistics
Market Cap 2 M Forward PE -0.4778 Revenue Growth 0.00 %
Current Ratio 4.49 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 0.0980 Enterprise / Revenue -36.80 Price To Sales Trailing12 Months 142.48
Profitability
Profit Margins 0.00 % Operating Margins -37907.43 %
Balance Sheet
Total Cash 4 M Total Cash Per Share 4.76 Total Debt 1 M
Total Debt To Equity 17.06 Current Ratio 4.49 Book Value Per Share 6.55
All Measures
Short Ratio 79.00 % Message Board Id finmb_51732680 Shares Short Prior Month 20574
Return On Equity -2.69 City Southlake Uuid 4248ae6b-5bf9-3528-825f-b590f53c4303
Previous Close 2.86 First Trade Date Epoch Utc 1 B Book Value 6.55
Beta 3.29 Total Debt 1 M Volume 16154
Price To Book 0.4430 Last Split Date 1 B Fifty Two Week Low 2.36
Total Cash Per Share 4.76 Total Revenue 18600 Shares Short Previous Month Date 1 B
Target Median Price 13.50 Max Age 86400 Sand P52 Week Change 0.3133
Operating Margins -37907.43 % Target Mean Price 13.50 Net Income To Common -7290042
Short Percent Of Float 0.0337 Implied Shares Outstanding 913821 Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 19250 Average Volume10days 19250
Total Cash 4 M Next Fiscal Year End 1 B Revenue Per Share 0.0360
Held Percent Insiders 0.1064 Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 2.86 Target Low Price 12.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 3.38 Open 2.94
Free Cashflow -4563570 State TX Dividend Yield 0.00 %
Return On Assets -0.8169 Time Zone Short Name EST Trailing Eps -8.41
Day Low 2.86 Address1 550 Reserve Street Shares Outstanding 913821
Price Hint 4 Target High Price 15.00 Website https://heartsciences.com
52 Week Change -0.8802 Average Volume 362210 Forward Eps -6.08
Recommendation Key none Compensation As Of Epoch Date 1 B Quick Ratio 321.10 %
Last Split Factor 1:100 Regular Market Day High 3.00 Is_sp_500 False
Profit Margins 0.00 % Debt To Equity 17.06 Fifty Two Week High 25.10
Day High 3.00 Shares Short 30472 Regular Market Open 2.94
Industry Key medical-devices Earnings Growth 0.00 % Enterprise To Revenue -36.80
Revenue Growth 0.00 % Shares Percent Shares Out 0.0333 Operating Cashflow -6684640
Currency USD Time Zone Full Name America/New_York Market Cap 2 M
Is_nasdaq_100 False Zip 76092 Quote Type EQUITY
Industry Medical Devices Long Name HeartSciences Inc. Regular Market Day Low 2.86
Held Percent Institutions 0.0143 Current Price 2.90 Address2 Suite 360
Enterprise To Ebitda 0.0980 Financial Currency USD Current Ratio 4.49
Gross Margins 67.31 % Industry Disp Medical Devices Number Of Analyst Opinions 2
Country United States Float Shares 826304 Two Hundred Day Average 6.27
Enterprise Value -684422 Price To Sales Trailing12 Months 142.48 Forward PE -0.4778
Regular Market Volume 16154 Ebitda -7018364 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha
HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to enhance its clinical utility.

It is developing artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction and conventional ECG information in the same test; and MyoVista Insights, a cloud-based platform to host AI-ECG algorithms on an ECG hardware agnostic basis.

The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024.

HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.